• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX HOLLOW FIBER OXYGENATOR/ARTERIAL FILTER; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX HOLLOW FIBER OXYGENATOR/ARTERIAL FILTER; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number CX-FX05RE
Device Problem Increase in Pressure (1491)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/26/2021
Event Type  Injury  
Manufacturer Narrative
Udi - not required for product code.Implanted date: device was not implanted.Explanted date: device was not explanted.Occupation- (b)(6).Pma/510(k)- k130280.The actual sample was received for evaluation.Visual inspection revealed no breakage in the visible range.The actual sample was rinsed, dried, and built into a circuit with tube.Bovine blood (hct35% and temp.37°c) was circulated at 1.5l/min in the circuit, while the pressure drop was determined.The obtained values were confirmed to meet the factory's specifications.No blockage was confirmed.The blood that had remained in the circuit was collected, fixed with glutaraldehyde-containing physiological saline solution, and then dried for electron microscopic inspection.Deformed red blood cells (echinocytes) were observed.A review of the device history record and product-release judgement record of the involved product code/lot# combination was conducted with no findings.Ifu states: do not reduce heparin during circulation.Otherwise, blood clotting might occur.Adequate heparinization of the blood is required to prevent it from clotting in the system.Based on the provided information and investigation results, there is no definitive evidence that this event was related to a device defect or malfunction.The investigation results verified the returned sample was of normal product.Based upon the description of the event that the priming was performed while removing water, and on the investigation result that the echinocytes was observed in the blood collected from the actual sample; it is likely that the blood viscosity increased due to increasing hct, which resulted in the oxygenator pressure rise; the blood fluidity decreased due to red blood cells having been deformed for some reason, which resulted in the oxygenator pressure rise.However, the exact cause of the reported event cannot be definitively determined based on the available information.Terumo medical products (tmp) (importer) registration no.2243441 is submitting this report on behalf of ashitaka factory of terumo corporation (manufacturer) registration no.(b)(4).
 
Event Description
The user facility reported that the capiox device was used during the procedure.Priming was performed with water first, and then blood was added while water was removed.The oxygenator pressure increased to 300.They felt anomaly and re-connected the pressure line to measure again, however found it increased around 400.The oxygenator was exchanged for a new one.Circuit and shunt sensor were changed out also.The procedure outcome was not reported.The patient was not harmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX HOLLOW FIBER OXYGENATOR/ARTERIAL FILTER
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, 418
JA   418
Manufacturer Contact
mary o'neill
reg. no. 2243441
950 elkton blvd.
elkton, MD 21921
8002837866
MDR Report Key11654664
MDR Text Key261208356
Report Number9681834-2021-00057
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K071572
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2023
Device Catalogue NumberCX-FX05RE
Device Lot Number201015
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/29/2021
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/26/2021
Initial Date FDA Received04/13/2021
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured10/15/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-